Publication Name	World Journal of Radiology
Manuscript ID	22001
Country	Germany

Received	2015-08-12 16:53
Peer-Review Started	2015-08-18 09:58
To Make the First Decision	2015-09-28 11:31
Return for Revision	2015-10-06 10:36
Revised	2015-10-17 17:10
Second Decision	2016-02-29 09:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-03-14 11:48
Articles in Press	2016-03-14 11:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-05-01 14:03
Publish the Manuscript Online	2016-05-18 10:38

ISSN	1949-8470 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type	Review
Article Title	Current status of transarterial radioembolization
Manuscript Source	Invited Manuscript
All Author List	Andreas H Mahnken
Funding Agency and Grant Number
Corresponding Author	Andreas H Mahnken, MD, MBA, MME, Department of Diagnostic and Interventional Radiology, University Hospital, Philipps-University, Baldingerstrasse, 35043 Marburg, Germany. mahnken@med.uni-marburg.de
Key Words	Hepatocellular carcinoma; Selective internal radiation therapy; Radioembolization; Liver; Neoplasm; Metastasis
Core Tip	Transarterial radioembolization (TARE) with 90Y microspheres is a targeted therapy indicated for unresectable primary and secondary liver malignancies. Current data proves its safety and effectiveness, but its definitive role in the treatment of hepatocellular carcinoma and metastatic liver disease within inter-disciplinary treatment algorithms is still to be established. There is a strong need for randomized controlled trials comparing TARE to transarterial chemoembolization in primary liver cancer and to modern chemotherapeutic regimen in metastatic liver disease.
Publish Date	2016-05-18 10:38
Citation	Mahnken AH. Current status of transarterial radioembolization. World J Radiol 2016; 8(5): 449-459
URL	http://www.wjgnet.com/1949-8470/full/v8/i5/449.htm
DOI	http://dx.doi.org/10.4329/wjr.v8.i5.449

Full Article (PDF)	WJR-8-449.pdf
Full Article (Word)	WJR-8-449.doc
Manuscript File	22001-Review.doc
Answering Reviewers	22001-Answering reviewers.pdf
Audio Core Tip	22001-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	22001-Conflict-of-interest statement.pdf
Copyright License Agreement	22001-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	Informed_Consent_Statement_20150812162848.pdf
Peer-review Report	22001-Peer-review(s).pdf
Scientific Misconduct Check	22001-Scientific misconduct check.pdf
Scientific Editor Work List	22001-Scientific editor work list.pdf